In the near term, commercial efforts might raise the chances that new patients are prescribed Novo Nordisk’s drug, assuming ...

Despite its popularity, Ozempic often leads to temporary weight loss, carries serious side effects, and most users regain ...

At Little Fino, the newly opened bar and cafe at the William Vale in Williamsburg, compact choices include the “Mole Martinez ...

Struggling to find weight-loss drugs like Ozempic? Dr. Scourboutakos has 8 diet hacks that mimic the effects of GLP-1 meds ...

Frankly: Yes. The people who go to fine dining restaurants are, by definition, rich. They can all afford Mounjaro and Ozempic. And most are a little concerned about their weight. They have already ...

Scripta Insights, the doctor-driven, AI-powered pharmacy navigation company that guides self-insured employers, health plans and their members to prescription savings, announces today its GLP-1 ...

Semaglutide is associated with a high prevalence of adverse events, and its long-term safety is unknown. In an observational ...

Eli Lilly plans to pursue approval for its new GLP-1 pill by the end of this year. Fact checked by Nick Blackmer A daily pill ...

GoodRx ran a 12-month survey to better understand the dynamics that shape prescription medication fills and consumer behavior ...

Alzheimer's disease costs the global economy $1.3trillion a year. That is the estimate from the Alzheimer's Society.

NVO stock declines 3% as the company announces that Lars Fruergaard Jorgensen will be stepping down as the CEO.

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of ...